HERA Accepting Applications for Sean Patrick Collaborative Grant

April 10, 2012

Annual Award Provides $50K to Cross-Disciplinary Ovarian Cancer Researchers

DENVERApril 12, 2012 – The HERA Women’s Cancer Foundation, a nationally recognized ovarian cancer non-profit, is now accepting applications for the Sean Patrick Multidisciplinary Collaborative Grant, an annual award providing $50,000 for a cross-disciplinary collaborative research project. Applications must identify two or more scientists with different yet complementary skills and explain how these skills will be synergistic in addressing ovarian cancer. Applications are due June 1, 2012, and recipients will be selected in August.

Sean Patrick, for whom the grant was named, was a champion for innovative ovarian cancer research. She was frustrated that traditional chemotherapies had not changed the prognosis of ovarian cancer in decades and by the disproportionate amount of government funds that went to other cancers. To change this course, she founded the HERA Women’s Cancer Foundation in 2002 with the mission of stopping the loss of women from ovarian cancer by promoting Health, Empowerment, Research, and Awareness. 

Ms. Patrick believed that therapies with the most potential would be formulated by combining great ideas from different labs and fields. This grant is in honor of her vision and aims to give scientists the opportunity to work together and test ideas that may not be fundable by other agencies. HERA funds other science grants to encourage “outside the box” ideas for researching new directions in the treatment, early detection and prevention of ovarian cancer.  

The 2011 winners of the Sean Patrick Multidisciplinary Collaborative Grant were Monique Spillman, assistant professor in the Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, at the University of Colorado School of Medicine, and Lynne Bemis, an associate professor in the Division of Medical Oncology also at the UCSOM. Through collaborative research, these scientists are working to create a new technology to develop an urgently needed sensitive biomarker for the detection of ovarian cancer.  

For more information about the grant, past winners, eligibility and application instructions, visit the website. Applications and questions should be directed to Meg Steitz, HERA’s Executive Director, at meg@herafoundation.beta.mystagedsite.com or (970) 948-7360.

About the HERA Foundation:

Established in 2002, the HERA Women’s Cancer Foundation is a nationally-recognized 501(c)(3) nonprofit organization whose mission is to stop the loss of women from ovarian cancer by promoting Health, Empowerment, Research, and Awareness. As a nationally recognized ovarian cancer organization, HERA provides funding for cutting-edge research grants to scientists at respected medical institutions. In so doing, HERA attracts more young researchers to expand the scientific understanding of ovarian cancer while improving the lives of those battling the disease. In addition, HERA awards grants to local community groups to raise awareness about the disease in novel and unusual ways. More information is available at www.herafoundation.org.

 Media Contact:

Staci Busby

(303) 810-6500


news image strip